SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-167198
Filing Date
2021-05-20
Accepted
2021-05-20 07:10:32
Documents
13
Period of Report
2021-05-18
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d185934d8k.htm   iXBRL 8-K 29662
2 EX-99.1 d185934dex991.htm EX-99.1 11350
  Complete submission text file 0001193125-21-167198.txt   170351

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA alks-20210518.xsd EX-101.SCH 3093
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE alks-20210518_lab.xml EX-101.LAB 18070
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE alks-20210518_pre.xml EX-101.PRE 11399
6 EXTRACTED XBRL INSTANCE DOCUMENT d185934d8k_htm.xml XML 3379
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Filer) CIK: 0001520262 (see all company filings)

IRS No.: 981007018 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35299 | Film No.: 21942355
SIC: 2834 Pharmaceutical Preparations